Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5901828 | Growth Hormone & IGF Research | 2011 | 7 Pages |
Abstract
The clinical data of the patient combined with the laboratory data support the diagnosis of partial IGHD type II. Since the GH deficiency was not total, additional binding and signaling studies were performed, which revealed that the GH-P59L variant displays some of the common features of bioinactive GH syndrome. Taken together, in this study we report a patient suffering from the combination of two growth disorders (alteration of secretion as well as bioactivity) caused by a GH-1 gene alteration highlighting the necessity of functional analysis of any GH variant, despite the presence of obvious clinical features of IGHD type II.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Vibor Petkovic, Andrée Eblé, Amit V. Pandey, Marta Betta, Patrizia Mella, Christa E. Flück, Fabio Buzi, Primus E. Mullis,